Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.10
Delayed Data
As of Feb 05
 -0.25 / -3.94%
Today’s Change
3.93
Today|||52-Week Range
8.48
-22.49%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close6.35
Today’s open6.35
Day’s range6.05 - 6.35
Volume334,293
Average volume (3 months)402,235
Market cap$368.1M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-121.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+31.00%
P/E ratioNM
Price/Sales2.68
Price/Book6.08

Competitors

 Today’s
change
Today’s
% change
CTICCTi Biopharma Corp-0.02-1.75%
RDNTRadNet Inc-0.43-7.68%
NVTAInvitae Corp0.000.00%
GNMKGenMark Diagnostics ...-0.42-7.64%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$87.1M
Annual profit (last year)$1.1M
Net profit margin1.30%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers